
Results
2
High Growth Stocks
2 companies
argenx
Market Cap: €44.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€715.60
7D
2.1%
1Y
41.3%
Kinepolis Group
Market Cap: €793.1m
Operates and manages cinemas in Belgium, Canada, France, the Netherlands, the United States, Spain, Luxembourg, and Switzerland.
KIN
€29.65
7D
1.2%
1Y
-14.7%